Skip to main content
SpringerLink
Log in

Breast Cancer Epidemiology

  • Chapter
  • First Online:
Book cover Management of Breast Diseases

Abstract

Breast cancer is the most frequent cancer in women and still one of the most common causes of cancer-related deaths in women worldwide. In 2012, 1.7 million cases of breast cancer were estimated by the WHO, with a different distribution in the burden of disease. In this chapter, relevant aspects of the epidemiology of breast cancer with an international perspective, including incidence, mortality and prevalence rates, are presented. Additionally, different aspects on modifiable and non-modifiable risk factors of breast cancer and their diverse impact in women are introduced, such as age, genetic predispositions, anthropometric measures, hormones, breast density, ionizing radiation and diet/lifestyle. In regard to prevention of breast cancer, women can perceive different kinds of primary and secondary prevention measures. For secondary prevention, mammography screening is offered in many countries to women over 50 years. This chapter includes a summary on the latest update on mammography screening and other prevention possibilities. As breast cancer is a complex and heterogeneous disease, different prognostic factors are of great importance to predict on outcome and overall survival in women with breast cancer. The variety of prognostic factors and survival rates are also addressed in this book chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    Excluding non-melanoma skin cancer.

  2. 2.

    5-year net survival is the cumulative probability that cancer patients would have survived 5 years or more after diagnosis when background mortality was eliminated and differences in population mortality is not entered in the comparisons.

References

  1. World Health Organization, International Agency for Research on Cancer. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. 2012 [December 9, 2012]; Available from: http://globocan.iarc.fr/.

  2. Stewart EW, Wild CP. World cancer report 2014. Lyon: International Agency for Research on Cancer; 2014.

    Google Scholar 

  3. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, et al. SEER cancer statistics review 1975–2012 Bethesda, MD: National Cancer Institute; 2015 [updated based on November 2014 SEER data submission, posted to the SEER web site, April 2015, January 6, 2016]; Available from: http://seer.cancer.gov/csr/1975_2012/.

  4. Youlden DR, Cramb SM, Yip CH, Baade PD. Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer biol Med. 2014;11(2):101–15 Epub 2014/07/11.

    PubMed  PubMed Central  Google Scholar 

  5. Song Q-K, Li J, Huang R, Fan J-H, Zheng R-S, Zhang B-N, et al. Age of diagnosis of breast cancer in China: almost 10 years earlier than in the United States and the European Union. Asian Pac J Cancer Prev. 2015;15(22):10021.

    Google Scholar 

  6. Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet. 2006;367(9510):595–604 Epub 2006/02/21.

    Article  PubMed  Google Scholar 

  7. Robert Koch-Institute. Cancer in Germany 2009/2010 [Krebs in Deutschland 2009/2010]. 9th ed. Berlin 2013.

    Google Scholar 

  8. Cancer Research UK 2014. Breast cancer in men. 2014 [updated July 30, 2014, December 16, 2015]; Available from: http://www.cancerresearchuk.org/about-cancer/type/rare-cancers/rare-cancers-name/breast-cancer-in-men.

  9. Association of the Nordic Cancer Registries (NORDCAN). NORDCAN, Cancer stat fact sheets. 2015 [updated December 11, 2015, December 16, 2015]; Available from: http://www-dep.iarc.fr/NORDCAN/english/StatsFact.asp?cancer=200&country=0.

  10. American Cancer Society. What are the key statistics about breast cancer? 2015 [updated October 6, 2015 December 16, 2015]; Available from: http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-key-statistics.

  11. GEKID. [GEKID Atlas - Tabellenabfrage]. 2012 [January 05, 2016]; Available from: http://www.gekid.de/Atlas/Tabellen/Tabellen_D.php?Method=INCIDENCE_EU&ICD10=C50&Year_from=2012&Year_to=2012&Men=on&Women=on&Cases=on.

  12. World, Health, Organization. Global Health Observatory, Visualizations, Causes of death - Ten leading causes of death. 2012 [December 10, 2015]; Available from: http://www.who.int/gho/mortality_burden_disease/causes_death/top_10/en/.

  13. Cancer Research UK 2013. Cancer mortality by age. 2013 [updated December 4, 2013 January 6, 2016]; Available from: http://www.cancerresearchuk.org/content/cancer-mortality-by-age#heading-Two.

  14. Singletary SE. Rating the risk factors for breast cancer. Ann Surg. 2003;237(4):474–82 Epub 2003/04/05.

    PubMed  PubMed Central  Google Scholar 

  15. Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer J Int du Cancer. 1997;71(5):800–9 Epub 1997/05/29.

    Article  CAS  Google Scholar 

  16. Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet. 2001;358(9291):1389–99 Epub 2001/11/14.

    Article  Google Scholar 

  17. Slattery ML, Kerber RA. A comprehensive evaluation of family history and breast cancer risk. The Utah Population Database. JAMA. 1993;270(13):1563–8 Epub 1993/10/06.

    Article  CAS  PubMed  Google Scholar 

  18. Dossus L, Benusiglio PR. Lobular breast cancer: incidence and genetic and non-genetic risk factors. Breast Cancer Res: BCR. 2015;17:37 Epub 2015/04/08.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Lalloo F, Evans DG. Familial breast cancer. Clin Genet. 2012;82(2):105–14 Epub 2012/02/24.

    Article  CAS  PubMed  Google Scholar 

  20. Chompret A, Brugieres L, Ronsin M, Gardes M, Dessarps-Freichey F, Abel A, et al. P53 germline mutations in childhood cancers and cancer risk for carrier individuals. Br J Cancer. 2000;82(12):1932–7 Epub 2000/06/23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Couch FJ, Nathanson KL, Offit K. Two decades after BRCA: setting paradigms in personalized cancer care and prevention. Science. 2014;343(6178):1466–70 Epub 2014/03/29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature. 2007;447(7148):1087–93 Epub 2007/05/29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Stone J, Thompson DJ, Dos Santos Silva I, Scott C, Tamimi RM, Lindstrom S, et al. Novel associations between common breast cancer susceptibility variants and risk-predicting mammographic density measures. Cancer Res. 2015;75(12):2457–67 Epub 2015/04/12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Zhang B, Shu XO, Delahanty RJ, Zeng C, Michailidou K, Bolla MK, et al. Height and breast cancer risk: evidence from prospective studies and mendelian randomization. J Natl Cancer Inst. 2015;107(11). Epub 2015/08/25.

    Google Scholar 

  25. van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000;152(6):514–27 Epub 2000/09/21.

    Article  PubMed  Google Scholar 

  26. McTiernan A. Behavioral risk factors in breast cancer: can risk be modified? Oncologist. 2003;8(4):326–34 Epub 2003/08/05.

    Article  PubMed  Google Scholar 

  27. Collaborative Group on Hormonal Factors in Breast Cancer. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol. 2012;13(11):1141–51 Epub 2012/10/23.

    Article  PubMed Central  Google Scholar 

  28. National Breast and Ovarian Cancer Centre (NBOCC). Breast cancer risk factors: a review of the evidence. 2009.

    Google Scholar 

  29. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet. 2002;360(9328):187–95 Epub 2002/07/23.

    Article  Google Scholar 

  30. Renehan AG, Zwahlen M, Minder C, O’Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet. 2004;363(9418):1346–53 Epub 2004/04/28.

    Article  CAS  PubMed  Google Scholar 

  31. Gierisch JM, Coeytaux RR, Urrutia RP, Havrilesky LJ, Moorman PG, Lowery WJ, et al. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer Epidemiol Biomark Prev. 2013;22(11):1931–43 Epub 2013/09/10, A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.

    Article  Google Scholar 

  32. Narod SA. Hormone replacement therapy and the risk of breast cancer. Nat Rev Clin Oncol. 2011;8(11):669–76 Epub 2011/08/03.

    Article  CAS  PubMed  Google Scholar 

  33. Friis S, Kesminiene A, Espina C, Auvinen A, Straif K, Schuz J. European code against cancer 4th edition: medical exposures, including hormone therapy, and cancer. Cancer Epidemiol. 2015;39(Suppl 1):S107–19 Epub 2015/09/24.

    Article  PubMed  Google Scholar 

  34. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev. 2006;15(6):1159–69 Epub 2006/06/16, A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

    Article  Google Scholar 

  35. Dyrstad SW, Yan Y, Fowler AM, Colditz GA. Breast cancer risk associated with benign breast disease: systematic review and meta-analysis. Breast Cancer Res Treat. 2015;149(3):569–75 Epub 2015/02/01.

    Article  CAS  PubMed  Google Scholar 

  36. Seitz HK, Pelucchi C, Bagnardi V, La Vecchia C. Epidemiology and pathophysiology of alcohol and breast cancer: Update 2012. Alcohol and alcoholism (Oxford, Oxfordshire). 2012;47(3):204–12. Epub 2012/03/31.

    Google Scholar 

  37. Aune D, Chan DS, Vieira AR, Rosenblatt DA, Vieira R, Greenwood DC, et al. Fruits, vegetables and breast cancer risk: a systematic review and meta-analysis of prospective studies. Breast Cancer Res Treat. 2012;134(2):479–93 Epub 2012/06/19.

    Article  CAS  PubMed  Google Scholar 

  38. Zheng JS, Hu XJ, Zhao YM, Yang J, Li D. Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies. BMJ. 2013;346:f3706 Epub 2013/07/03.

    Article  PubMed  Google Scholar 

  39. Hu F, Wang Yi B, Zhang W, Liang J, Lin C, Li D, et al. Carotenoids and breast cancer risk: a meta-analysis and meta-regression. Breast Cancer Res Treat. 2012;131(1):239–53 Epub 2011/09/09.

    Article  CAS  PubMed  Google Scholar 

  40. Zhang YF, Shi WW, Gao HF, Zhou L, Hou AJ, Zhou YH. Folate intake and the risk of breast cancer: a dose-response meta-analysis of prospective studies. PloS One. 2014;9(6):e100044. Epub 2014/06/17.

    Google Scholar 

  41. Monninkhof EM, Elias SG, Vlems FA, van der Tweel I, Schuit AJ, Voskuil DW, et al. Physical activity and breast cancer: a systematic review. Epidemiology. 2007;18(1):137–57 Epub 2006/11/30.

    Article  PubMed  Google Scholar 

  42. Colditz GA, Bohlke K. Priorities for the primary prevention of breast cancer. CA Cancer J Clin. 2014;64(3):186–94 Epub 2014/03/22.

    Article  PubMed  Google Scholar 

  43. Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. New Engl J Med. 1999;340(2):77–84 Epub 1999/01/14.

    Article  CAS  PubMed  Google Scholar 

  44. Howell A, Anderson AS, Clarke RB, Duffy SW, Evans DG, Garcia-Closas M, et al. Risk determination and prevention of breast cancer. Breast cancer research: BCR. 2014;16(5):446. Epub 2014/12/04.

    Google Scholar 

  45. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, et al. Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study. J Natl Cancer Inst. 1998;90(18):1371–88 Epub 1998/09/25.

    Article  CAS  PubMed  Google Scholar 

  46. Visvanathan K, Hurley P, Bantug E, Brown P, Col NF, Cuzick J, et al. Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013;31(23):2942–62 Epub 2013/07/10, Official journal of the American Society of Clinical Oncology.

    Article  PubMed  Google Scholar 

  47. Domchek SM, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs C, et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 2010;304(9):967–75 Epub 2010/09/03.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van ‘t Veer L, Garber JE, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol. 2004;22(6):1055–62 Epub 2004/02/26, Official journal of the American Society of Clinical Oncology.

    Article  PubMed  Google Scholar 

  49. Claus EB, Risch N, Thompson WD. The calculation of breast cancer risk for women with a first degree family history of ovarian cancer. Breast Cancer Res Treat. 1993;28(2):115–20 Epub 1993/11/01.

    Article  CAS  PubMed  Google Scholar 

  50. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(24):1879–86 Epub 1989/12/20.

    Article  CAS  PubMed  Google Scholar 

  51. Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med. 2004;23(7):1111–30 Epub 2004/04/02.

    Article  PubMed  Google Scholar 

  52. Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, et al. Breast-cancer screening–viewpoint of the IARC Working Group. New Engl J Med. 2015;372(24):2353–8 Epub 2015/06/04.

    Article  CAS  PubMed  Google Scholar 

  53. U.S. Preventive Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Annals of internal medicine. 2009;151(10):716–26, W-236. Epub 2009/11/19.

    Google Scholar 

  54. Kosters JP, Gotzsche PC. Regular self-examination or clinical examination for early detection of breast cancer. The Cochrane database of systematic reviews. 2003(2):CD003373. Epub 2003/06/14.

    Google Scholar 

  55. Weiss NS. Breast cancer mortality in relation to clinical breast examination and breast self-examination. Breast J. 2003;9(Suppl 2):S86–9 Epub 2003/04/26.

    Article  PubMed  Google Scholar 

  56. Gotzsche PC, Jorgensen KJ. Screening for breast cancer with mammography. The Cochrane database of systematic reviews. 2013;6:CD001877. Epub 2013/06/06.

    Google Scholar 

  57. Independent UK. Panel on breast cancer screening. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012;380(9855):1778–86 Epub 2012/11/03.

    Article  Google Scholar 

  58. The Hague, Netherlands HCot. Health Council of the Netherlands. Population screening for breast cancer: expectations and developments. 2014;publication no. 2014/01.

    Google Scholar 

  59. Fügemann H, Kääb-Sanyal V. Mammographie-Screening: Nutzen-Schaden-Abwägung im internationalen Vergleich. Deutsches Ärzteblatt. 2016;113(3).

    Google Scholar 

  60. Gesundheitswesen IfQuWi. Einladungsschreiben und Merkblatt zum Mammographie-Screening. Rapid Report. IQWiG-Berichte – Nr. 288. 2015.

    Google Scholar 

  61. Paci E, Group EW. Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet. J Med Screen. 2012;19(Suppl 1):5–13 Epub 2012/11/08.

    Article  Google Scholar 

  62. Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385(9972):977–1010 Epub 2014/12/04.

    Article  PubMed  Google Scholar 

  63. Clark GM. Prognostic and Predictive Factors for Breast Cancer. Breast Cancer (Tokyo, Japan). 1995;2(2):79–89. Epub 1995/10/31.

    Google Scholar 

  64. Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E, et al. Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v8–30 Epub 2015/09/01, Official journal of the European Society for Medical Oncology/ESMO.

    Article  PubMed  Google Scholar 

  65. Ly ALS, Dillon D. Prognostic factors for patients with breast cancer: traditional and new. Surg Pathol. 2012;5:775–85.

    Article  Google Scholar 

  66. Blamey RW, Pinder SE, Ball GR, Ellis IO, Elston CW, Mitchell MJ, et al. Reading the prognosis of the individual with breast cancer. Eur J Cancer. 2007;43(10):1545–7 Epub 2007/02/27.

    Article  CAS  PubMed  Google Scholar 

  67. Ravdin PM, Siminoff LA, Davis GJ, Mercer MB, Hewlett J, Gerson N, et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol. 2001;19(4):980–91 Epub 2001/02/22, Official Journal of the American Society of Clinical Oncology.

    Article  CAS  PubMed  Google Scholar 

  68. Soerjomataram I, Louwman MW, Ribot JG, Roukema JA, Coebergh JW. An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat. 2008;107(3):309–30 Epub 2007/03/23.

    Article  CAS  PubMed  Google Scholar 

  69. Holleczek B, Brenner H. Provision of breast cancer care and survival in Germany—results from a population-based high resolution study from Saarland. BMC Cancer. 2014;14:757 Epub 2014/10/12.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Allemani C, Sant M, Weir HK, Richardson LC, Baili P, Storm H, et al. Breast cancer survival in the US and Europe: a CONCORD high-resolution study. Int J Cancer J Int du Cancer. 2013;132(5):1170–81 Epub 2012/07/21.

    Article  CAS  Google Scholar 

  71. Subramaniam DS, Isaacs C. Utilizing prognostic and predictive factors in breast cancer. Curr Treat Options Oncol. 2005;6(2):147–59 Epub 2005/02/19.

    Article  PubMed  Google Scholar 

  72. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19(5):403–10 Epub 1991/11/01.

    Article  CAS  PubMed  Google Scholar 

  73. Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957;11(3):359–77 Epub 1957/09/01.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Kos Z, Dabbs DJ. Biomarker assessment and molecular testing for prognostication in breast cancer. Histopathology. 2016;68(1):70–85 Epub 2016/01/16.

    Article  PubMed  Google Scholar 

  75. Tinnemans JG, Beex LV, Wobbes T, Sluis RF, Raemaekers JM, Benraad T. Steroid-hormone receptors in nonpalpable and more advanced stages of breast cancer. A contribution to the biology and natural history of carcinoma of the female breast. Cancer. 1990;66(6):1165–7 Epub 1990/09/15.

    Article  CAS  PubMed  Google Scholar 

  76. Fisher B, Redmond C, Fisher ER, Caplan R. Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. J Clin Oncol. 1988;6(7):1076–87 Epub 1988/07/01, Official Journal of the American Society of Clinical Oncology.

    Article  CAS  PubMed  Google Scholar 

  77. Weigel MT, Dowsett M. Current and emerging biomarkers in breast cancer: prognosis and prediction. Endocr Relat Cancer. 2010;17(4):R245–62 Epub 2010/07/22.

    Article  CAS  PubMed  Google Scholar 

  78. Reed W, Hannisdal E, Boehler PJ, Gundersen S, Host H, Marthin J. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14–30 years. Cancer. 2000;88(4):804–13 Epub 2000/02/19.

    Article  CAS  PubMed  Google Scholar 

  79. Menard S, Balsari A, Casalini P, Tagliabue E, Campiglio M, Bufalino R, et al. HER-2-positive breast carcinomas as a particular subset with peculiar clinical behaviors. Clin Cancer Res. 2002;8(2):520–5 Epub 2002/02/13, An official journal of the American Association for Cancer Research.

    CAS  PubMed  Google Scholar 

  80. Toss A, Cristofanilli M. Molecular characterization and targeted therapeutic approaches in breast cancer. Breast Cancer Res: BCR. 2015;17:60 Epub 2015/04/24.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Coates AS, Winer EP, Goldhirsch A, Gelber RD, Gnant M, Piccart-Gebhart M, et al. Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. Ann Oncol. 2015;26(8):1533–46 Epub 2015/05/06, Official journal of the European Society for Medical Oncology/ESMO.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Hankinson S, Tamini R, Hunter D. Breast cancer. In: Adami HO, Hunter D, Trichopoulos D, editors. Textbook of cancer epidemiology. 2nd ed 2008.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of Texas Health Science Center at San Antonio, San Antonio, TX, 78229, USA

    Alicia Brunßen

  2. Institute for Social Medicine and Epidemiology, University of Luebeck, Ratzeburger Allee 160 (Hs. 50), Luebeck, 23562, Schleswig-Holstein, Germany

    Joachim Hübner, Alexander Katalinic, Maria R. Noftz & Annika Waldmann

Authors
  1. Alicia Brunßen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joachim Hübner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexander Katalinic
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maria R. Noftz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Annika Waldmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexander Katalinic .

Editor information

Editors and Affiliations

  1. Department of Surgery, University of Texas Health Science Center, San Antonio, Texas, USA

    Ismail Jatoi

  2. Obstetrics and Gynecology, University Medical Center Schleswig-Holstein, Luebeck, Germany

    Achim Rody

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Brunßen, A., Hübner, J., Katalinic, A., Noftz, M.R., Waldmann, A. (2016). Breast Cancer Epidemiology. In: Jatoi, I., Rody, A. (eds) Management of Breast Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-46356-8_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-46356-8_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-46354-4

  • Online ISBN: 978-3-319-46356-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation